Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV001105247 | SCV001262186 | uncertain significance | Ornithine aminotransferase deficiency | 2017-04-28 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. |
Labcorp Genetics |
RCV001105247 | SCV001420251 | likely benign | Ornithine aminotransferase deficiency | 2024-10-29 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV001105247 | SCV001524618 | uncertain significance | Ornithine aminotransferase deficiency | 2020-04-13 | criteria provided, single submitter | clinical testing | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. |
Ambry Genetics | RCV004032108 | SCV004994435 | uncertain significance | Inborn genetic diseases | 2023-09-26 | criteria provided, single submitter | clinical testing | The c.478G>A (p.V160M) alteration is located in exon 4 (coding exon 3) of the OAT gene. This alteration results from a G to A substitution at nucleotide position 478, causing the valine (V) at amino acid position 160 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Natera, |
RCV001105247 | SCV001467298 | uncertain significance | Ornithine aminotransferase deficiency | 2020-04-11 | no assertion criteria provided | clinical testing |